Attention Deficit Hyperactivity Disorder (ADHD) and Autism Pathway services NHS North East and North Cumbria (Patient Choice)

NHS North East and North Cumbria Integrated Care Board (NENC ICB) has awarded a contract for the provision of Attention Deficit Hyperactivity Disorder (ADHD) and Autism diagnostic and assessment pathway services under the patient choice framework. The service includes assessment, diagnosis, post-diagnostic support, and associated clinical interventions delivered in accordance with relevant national guidance and local pathway requirements.

The contract has been awarded to NHS North East and North Cumbria Integrated Care Board following Direct Award Process B under the The Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award.

This contract covers ADHD and Autism diagnostic and treatment pathway services across the NENC ICB footprint.

The service operates on an activity-based tariff model. The estimated total value shown reflects the highest unit tariff for the purposes of system entry. Payment is made on an activity basis and there is no guaranteed minimum activity.

Supplier details as published

Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.

Lots

This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.

Government spending data: This supplier has received £309,527 in 8 payments (over £25k) from Manchester University NHS Foundation Trust (2022-08-19 to 2024-03-26). View full payment history →